Function
Positively regulates the transcription of MYCNOS in neuroblastoma cells.
Biological Context
Subcellular Location: Nucleus
Tissue Specificity: Expressed in the neuronal cells of the cerebrum, neuroblastomas and thyroid tumors (at protein level)
Disease Association: [Amplification of the N-MYC gene is associated with a variety of human tumors, most frequently neuroblastoma, where the level of amplification appears to increase as the tumor progresses] | Feingold syndrome 1 (FGLDS1) : A syndrome characterized by variable combinations of esophageal and duodenal atresias, microcephaly, learning disability, intellectual disability, and limb malformations. Hand and foot abnormalities may include hypoplastic thumbs, clinodactyly of second and fifth fingers, syndactyly (characteristically between second and third and fourth and fifth toes), and shortened or absent middle phalanges. Cardiac and renal malformations, vertebral anomalies, and deafness have also been described. [The disease is caused by variants affecting the gene represented in this entry] | Megalencephaly-polydactyly syndrome (MPAPA) : An autosomal dominant syndrome characterized by megalencephaly, ventriculomegaly, postaxial polydactyly, and increased risk of neuroblastoma. [The disease is caused by variants affecting the gene represented in this entry]
Product Specifications
Recombinant Human N-myc proto-oncogene protein (MYCN) is a recombinant protein from Homo sapiens (Human), expressed in Baculovirus, covering amino acids 1-464aa, with C-terminal 6xHis-tagged tag, molecular weight 52.4kDa, purity Greater than 90% as determined by SDS-PAGE.. Suitable for ELISA and Western Blot applications.
